Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Surmodics Sees FY23 Adj EPS Of $(2.54)-$(2.14) vs. Consensus of $(1.23)

Expects the fiscal year 2023 total revenue of $103 million – $107 million versus the consensus of $99.76 million

byBenzinga Newsdesk

November 9, 2022

1 minute read

Expects the fiscal year 2023 total revenue of $103 million – $107 million versus the consensus of $99.76 million

Earnings

Return on Capital Employed Overview: Equifax

By Benzinga Insights

Today, 10:31 AM

Pulled from Benzinga Pro data Equifax (NYSE:EFX) posted a 0.2% decrease in earnings from Q1. Sales, however, increased by 1.8% over the previous quarter to $1.23 billion.

EFX

Neogen Acquires CAPInnoVet For Undisclosed Sum

By Vandana Singh

Today, 10:31 AM

Neogen Corporation (NASDAQ:NEOG) has acquired CAPInnoVet, Inc, an Atlanta-based companion animal health company. Deal terms were not disclosed. CAPInnoVet, founded in…

NEOG

SenesTech Q2 EPS $(0.10) Beats $(0.15) Estimate, Sales $160.00K Beat $90.00K Estimate

By Bill Haddad

Today, 10:31 AM

SenesTech (NASDAQ:SNES) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.15) by 33.33 percent. This is a 83.05 percent increase over losses of $(0.59) per share from the

SNES